Polyether-ether-ketone (PEEK) has emerged in Implant Dentistry with a series of short-time applications and as a promising material to substitute definitive dental implants. Several strategies have been investigated to diminish biofilm formation on the PEEK surface aiming to decrease the possibility of related infections. Therefore, a comprehensive review was carried out in order to compare PEEK with materials widely used nowadays in Implant Dentistry, such as titanium and zirconia, placing emphasis on studies investigating its ability to grant or prevent biofilm formation. Most studies failed to reveal significant antimicrobial activity in pure PEEK, while several studies described new strategies to reduce biofilm formation and bacterial colonization on this material. Those include the PEEK sulfonation process, incorporation of therapeutic and bioactive agents in PEEK matrix or on PEEK surface, PEEK coatings and incorporation of reinforcement agents, in order to produce nanocomposites or blends. The two most analyzed surface properties were contact angle and roughness, while the most studied bacteria were Escherichia coli and Staphylococcus aureus. Despite PEEK’s susceptibility to biofilm formation, a great number of strategies discussed in this study were able to improve its antibiofilm and antimicrobial properties.
A series of 32 novel potential bacterial biofilm inhibitor analogues of rubrolides and their lactam derivatives were synthesized. The compounds were prepared and tested against Staphylococcus aureus and Staphylococcus epidermidis. In general, γ-alkylidene-γ-lactams are more active than the corresponding γ-alkylidene-γ-lactones, and the two derivatives are more effective in inhibiting bacterial planktonic growth (IC50 of 1.8 and 5.6 μg mL–1) than natural rubrolides. Compounds showing little effect on planktonic growth were assayed for their ability to inhibit biofilm formation. As biofilm inhibitors, none of the new compounds were effective against S. epidermidis, whereas the three Z-lactam derivatives were very active against S. aureus (IC50 = 0.9–3.3 μg mL–1). The strong antibiofilm formation activity displayed by some γ-alkylidene-γ-lactams indicates that this may represent a promising class of compounds for the development of novel antimicrobial agents against clinically relevant Gram-positive bacteria.